Concept and diagnosis of intrauterine adhesions
Uterine cavity adhesion, also known as Asherman syndrome, is a disease of endometrial adhesion. Severe uterine cavity adhesion may lead to problems such as amenorrhea, irregular menstruation and infertility. Uterine cavity adhesion is generally caused by abnormal healing process after endometrial injury. Common reasons include uterine cavity surgery (such as curettage, caesarean section), endometritis, etc. The diagnosis of intrauterine adhesions mainly depends on medical history inquiry and imaging examination, such as ultrasound, hysteroscopy, etc.
In the gynaecological clinic of a hospital, after a detailed history inquiry and examination, the doctor found that the patient's endometrium had adhesion, and performed hysteroscopic surgery to further clarify the diagnosis.
Effect of intrauterine adhesion on test tube infants
Uterine adhesion will affect the success rate of IVF. First of all, uterine cavity adhesion will lead to the weakness or disappearance of endometrium, which will lead to poor conditions for embryo implantation and increase the risk of implantation failure. Secondly, intrauterine adhesions may change the shape and size of the uterus, further affecting the development and implantation of embryos. In addition, patients with intrauterine adhesions with a large range of adhesions may also lead to the inability of embryos to enter the uterine cavity, thus making it impossible to implement the IVF technology.
Therefore, for patients with intrauterine adhesions, the success rate of IVF is lower than that of normal women. This means that more IVF cycles and higher tolerance are needed to obtain a healthy baby.
Treatment of intrauterine adhesions
The treatment of intrauterine adhesions is mainly to restore the anatomical structure and function of endometrium through surgery. Common surgical methods include separation of adhesive tissue under hysteroscopy and implantation of intrauterine stent. Patients with small adhesions can promote endometrial regeneration through hormone therapy, while patients with large adhesions may need multiple operations to fully restore endometrial function. After surgery, hormone therapy and uterine cavity dilatation in the rehabilitation period are usually required to prevent re adhesion.
In the specific treatment process, patients usually need to choose an experienced gynecological hospital for treatment, and doctors will develop personalized treatment plans according to the specific conditions of patients, and conduct regular follow-up after surgery.
conclusion
Uterine cavity adhesion has a significant impact on IVF, which will reduce the success rate of IVF. However, for couples with intrauterine adhesions, it is not entirely hopeless. Through appropriate surgical treatment and individualized assisted reproductive technology programs, they still have the opportunity to achieve their reproductive aspirations. In the process of treatment, patients should choose a regular hospital and actively cooperate with the doctor's treatment plan to improve the chances of success.
